Sana Biotechnology to Sell Up to 15M Shares to Mayo Clinic

Sana Biotechnology, Inc. has entered into a Stock Purchase Agreement with Mayo Clinic, under which Mayo Clinic will initially purchase 7,507,507 shares of common stock for approximately $25 million. Mayo Clinic also has an option to acquire an additional 7,507,507 shares for another $25 million by August 31, 2026. This agreement is concurrent with a Collaboration and License Agreement aimed at advancing cell therapies, particularly for diabetes patients, with Mayo Clinic licensing certain intellectual property to Sana.